Tap into vast disruptive potential in the healthcare space
Genetic therapies are a once-in-a-generation healthcare breakthrough that could revolutionise the treatment of a vast range of diseases. The potential for disruption is enormous – for patients, for healthcare companies, for investors.
Share in early-stage growth
Capturing the genetic therapies opportunity
Our Genetic Therapies fund is powered by ThemeBot, the thematic investment engine from our Quantitative Beta Solutions. The fund harnesses the combined power of artificial intelligence and fundamental research, seeking to maximise exposure to the theme while minimising company-specific risk.